Degradation of a pharmaceutical in HPLC grade methanol containing trace level formaldehyde.
An anomalous peak was observed in the HPLC/UV analysis of a developmental drug product. High resolution LC/MS revealed that the mass of this degradant was 12 Da greater than the drug substance, corresponding to a net gain of a single carbon atom. The degradant was reproduced by incubating the drug substance with formaldehyde, followed by isolation using normal phase chromatography and structure elucidation by NMR. It was determined to be an analytical artifact caused by the nucleophilic reaction of the drug substance with trace levels of formaldehyde in the methanol diluent. Typical formaldehyde levels in various grades of methanol were determined, leading to the adoption of spectrophotometric purity solvent to mitigate the recurrence of this artifact. This work demonstrates that even ppm levels of impurities in solvents can cause significant degradation of drug product and the HPLC grade solvents are not always suitable for HPLC analysis in drug product development.
Department of Small Molecule Pharmaceutical Sciences, Genentech, Inc. 1 DNA Way, South San Francisco, CA, USA.
Qiqing
Q
Zhong
Sarah
S
Stowers
Nathaniel L
NL
Segraves
Kenley K
KK
Ngim
Ke
K
Zhang
Tracy
T
Bostick
Alan
A
Deese
Nik P
NP
Chetwyn
D016477:Artifacts; D001384:Azetidines / Q000737:chemistry / Q000592:standards; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D015195:Drug Design; D005557:Formaldehyde / Q000737:chemistry*; D009682:Magnetic Resonance Spectroscopy; D000432:Methanol / Q000737:chemistry* / Q000592:standards; D010880:Piperidines / Q000737:chemistry / Q000592:standards; D012997:Solvents / Q000737:chemistry* / Q000592:standards; D013056:Spectrophotometry, Ultraviolet
D001384:Azetidines; D010880:Piperidines; D012997:Solvents; D005557:Formaldehyde; C574276:cobimetinib; D000432:Methanol